Timur Seckin is a fourth-year medical student at the Burnett School of Medicine at TCU. He studied Molecular Biology at the University of California, Berkeley, where his early training laid the foundation for a career committed to advancing patient care through research and innovation. His research has focused on practical applications that bring real-world improvements to clinical outcomes, particularly in women’s health. As a co-founder of BlueZai, a medical diagnostics company leveraging deep learning, he has led efforts to develop innovative diagnostic tools for endometriosis. In collaboration with Dokuz Eylul University Hospital, he is currently investigating the Aqua Blue Contrast Technique™ (ABCt™) to enhance the detection of peritoneal endometriosis. This method, involving retroperitoneal methylene blue hydrodistension, significantly improves lesion visibility in challenging areas such as the posterior pelvic sidewalls. Early results have shown that ABCt™ is more effective than conventional methods in detecting and excising endometriotic lesions, which are often difficult to identify during standard laparoscopic procedures. Beyond endometriosis, his work bridges artificial intelligence and clinical practice, using deep learning to reduce diagnostic delays and improve treatment options for patients with reproductive health conditions. His goal is to ensure that these innovations lead to earlier diagnoses and better patient outcomes. In addition, he completed a research year at the NYU Grossman School of Medicine at the Center for Transplant and Applied Research. His research has centered on the prevalence of obesogenic medications in both adult and pediatric hemodialysis patients who are kidney transplant candidates. He developed and implemented the standard operating protocol for a prospective cohort study assessing frailty, cognition, and depression in patients undergoing weight loss therapy for transplant candidacy. His direct experience with patient recruitment and assessments has provided him with a unique perspective on how research can directly improve clinical care and expand access to transplantation.